[144] ExlService Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for ExlService Holdings, Inc. (EXLS) reports a proposed sale of 8,000 common shares through Fidelity Brokerage Services with an aggregate market value of $350,080. The filer acquired these shares on 01/29/2024 via restricted stock vesting and indicates the shares were compensation. The filing lists approximately 161,513,147 shares outstanding and an approximate sale date of 09/10/2025 on NASDAQ.

The notice is a routine disclosure under Rule 144 and includes the filer’s representation that they have no undisclosed material adverse information about the issuer.

Positive

• Regulatory compliance: Full Rule 144 disclosure filed including acquisition details, broker, and sale timing
• Transparency: Filer attests to no undisclosed material adverse information, supporting public disclosure standards

Negative

• Insider sale: The filer intends to sell shares received as compensation, which investors may note despite small size

Insights

Securities Analyst

TL;DR: Small, routine insider sale disclosure; not likely material to EXLS equity given size.

The filing documents a proposed sale of 8,000 common shares acquired through restricted stock vesting and identified as compensation. The aggregate market value reported is $350,080 and the proposed execution is through Fidelity on NASDAQ on 09/10/2025. Compared with the reported 161,513,147 shares outstanding, this position is very small and the filing functions primarily as regulatory transparency under Rule 144 rather than indicating a material shift in ownership.

Corporate Governance Expert

TL;DR: Proper Rule 144 disclosure completed; signature attests absence of undisclosed material information.

The form includes required details: acquisition date (01/29/2024), nature of acquisition (restricted stock vesting), nature of payment (compensation), broker details (Fidelity Brokerage Services), and an attestation regarding material information. This satisfies typical insider-sale disclosure expectations and preserves regulatory compliance. There is no indication in the filing of any trading plan adoption date or other atypical governance issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8000	350080.00	161513147	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/29/2024	Restricted Stock Vesting	Issuer			8000	01/29/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EXLS Form 144 disclose?

The filing discloses a proposed sale of 8,000 common shares acquired on 01/29/2024 by restricted stock vesting, to be sold via Fidelity with aggregate market value $350,080.

When is the approximate sale date listed on the EXLS Form 144?

The filing lists an approximate sale date of 09/10/2025 on NASDAQ.

How were the EXLS shares acquired that are being sold?

The shares were acquired through restricted stock vesting and the payment nature is listed as compensation.

Through which broker will the EXLS shares be sold?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Does the Form 144 state whether the filer knows of any undisclosed material adverse information?

Yes. By signing, the filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.